As of 2026-10-04, the Relative Valuation of Sensei Biotherapeutics Inc (SNSE) is (3,434.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.85 USD, the upside of Sensei Biotherapeutics Inc based on Relative Valuation is -24897.5%.
The range of the Relative Valuation is (3,036.64) - (3,658.84) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.1x - 26.6x | 24.9x |
| Forward P/E multiples | 20.9x - 26.9x | 25.0x |
| Fair Price | (3,036.64) - (3,658.84) | (3,434.46) |
| Upside | -22025.2% - -26517.6% | -24897.5% |
| Date | P/E |
| 2026-09-22 | -0.24 |
| 2026-09-21 | -0.24 |
| 2026-09-18 | -0.25 |
| 2026-09-17 | -0.26 |
| 2026-09-16 | -0.25 |
| 2026-09-15 | -0.26 |
| 2026-09-14 | -0.28 |
| 2026-09-11 | -0.27 |
| 2026-09-10 | -0.28 |
| 2026-09-09 | -0.26 |
| 2026-09-08 | -0.28 |
| 2026-09-04 | -0.29 |
| 2026-09-03 | -0.28 |
| 2026-09-02 | -0.28 |
| 2026-09-01 | -0.25 |
| 2026-08-31 | -0.24 |
| 2026-08-28 | -0.25 |
| 2026-08-27 | -0.25 |
| 2026-08-26 | -0.24 |
| 2026-08-25 | -0.25 |
| 2026-08-24 | -0.25 |
| 2026-08-21 | -0.23 |
| 2026-08-20 | -0.23 |
| 2026-08-19 | -0.24 |
| 2026-08-18 | -0.24 |
| 2026-08-17 | -0.24 |
| 2026-08-14 | -0.23 |
| 2026-08-13 | -0.21 |
| 2026-08-12 | -0.21 |
| 2026-08-11 | -0.22 |
| 2026-08-10 | -0.21 |
| 2026-08-07 | -0.18 |
| 2026-08-06 | -0.18 |
| 2026-08-05 | -0.18 |
| 2026-08-04 | -0.19 |
| 2026-08-03 | -0.20 |
| 2026-07-31 | -0.20 |
| 2026-07-30 | -0.21 |
| 2026-07-29 | -0.21 |
| 2026-07-28 | -0.21 |
| 2026-07-27 | -0.21 |
| 2026-07-24 | -0.21 |
| 2026-07-23 | -0.20 |
| 2026-07-22 | -0.21 |
| 2026-07-21 | -0.21 |
| 2026-07-20 | -0.20 |
| 2026-07-17 | -0.19 |
| 2026-07-16 | -0.19 |
| 2026-07-15 | -0.23 |
| 2026-07-14 | -0.24 |